Truist Financial Corp Amphastar Pharmaceuticals, Inc. Transaction History
Truist Financial Corp
- $62.9 Billion
- Q3 2024
A detailed history of Truist Financial Corp transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 5,725 shares of AMPH stock, worth $208,962. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,725
Previous 14,485
60.48%
Holding current value
$208,962
Previous $579,000
52.16%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
36.5MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$217 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$99 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$77.9 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$71.1 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$59 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.79B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...